Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,158
Recruiting: 2,260
Ph III recruiting: 268
Growth YoY: +12.2%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 351–400 of 413 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02847767	Dynamic Contrast Enhanced HCC SABR Liver Study	unknown	N/A	20	British Columbia Cancer AgencyOTHER	1	Jul 28, 2016	clinicaltrials
NCT02105168	Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment(MSN)	unknown	N/A	2,200	Gustave Roussy, Cancer Campus, Grand ParisOTHER	1	Jun 10, 2016	clinicaltrials